{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:34:26Z","timestamp":1787589266211,"version":"build-2736575974"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273994"],"award-info":[{"award-number":["82273994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3506600"],"award-info":[{"award-number":["2024YFC3506600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["23XD1404000"],"award-info":[{"award-number":["23XD1404000"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.117989","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:45:14Z","timestamp":1776383114000},"page":"117989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["The therapeutic role of natural compounds mediated through Nrf2 in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"250","author":[{"given":"Xinnan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-2626","authenticated-orcid":false,"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117989_b0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.117989_b0010","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0015","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117989_b0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117989_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40273-022-01140-y","article-title":"The economic burden of non-alcoholic steatohepatitis: a systematic review","volume":"40","author":"Witkowski","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bcp.2026.117989_b0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.117989_b0050","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bcp.2026.117989_b0065","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.117989_b0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","article-title":"Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis","volume":"13","author":"Cusi","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bcp.2026.117989_b0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117989_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2026.117989_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1617805","article-title":"Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2026.117989_b0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.freeradbiomed.2020.12.449","article-title":"Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress","volume":"164","author":"Mohammed","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0125","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0130","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.3748\/wjg.v28.i48.6909","article-title":"Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease","volume":"28","author":"Bukke","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.117989_b0135","article-title":"The nrf2 pathway in liver diseases","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/mol.112.084269","article-title":"Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model","volume":"84","author":"Shimozono","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/apt.13981","article-title":"Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117989_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-030-64872-5_18","article-title":"Beneficial effects of plant-derived natural products on non-alcoholic fatty liver disease","volume":"1308","author":"Simental-Mendia","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115274","article-title":"Phytochemicals for the treatment of metabolic diseases: evidence from clinical studies","volume":"165","author":"Luo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117989_b0160","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3390\/ijms24043748","article-title":"Natural products as modulators of nrf2 signaling pathway in neuroprotection","volume":"24","author":"Moratilla-Rivera","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biopha.2018.05.135","article-title":"Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice","volume":"105","author":"Yan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117989_b0170","doi-asserted-by":"crossref","first-page":"e00099","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.117989_b0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes Cells"},{"key":"10.1016\/j.bcp.2026.117989_b0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.117989_b0190","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/MCB.00677-14","volume":"34","author":"Meakin","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coph.2021.07.021","article-title":"A double-edged sword: the Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease","volume":"60","author":"Wang","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0200","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1440-1746.2012.07180.x","article-title":"Dysregulated expression of fatty acid oxidation enzymes and iron-regulatory genes in livers of Nrf2-null mice","volume":"27","author":"Tanaka","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0205","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101456R","article-title":"Hepatic lipid accumulation induced by a high-fat diet is regulated by Nrf2 through multiple pathways","volume":"36","author":"Qiu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.117989_b0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of nrf2 (NF-E2 p45-Related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell Mol Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2015.12.014","article-title":"Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development","volume":"91","author":"Ramadori","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166110","article-title":"Chronic activation of hepatic nrf2 has no major effect on fatty acid and glucose metabolism in adult mice","volume":"11","author":"Brachs","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117989_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101412","article-title":"Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: involvement of reduced PPARgamma expression","volume":"30","author":"Li","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0230","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117989_b0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.aohep.2019.11.010","article-title":"NRF-2 and nonalcoholic fatty liver disease","volume":"19","author":"Solano-Urrusquieta","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0240","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6799414","article-title":"Regulatory networks, management approaches, and emerging treatments of nonalcoholic fatty liver disease","volume":"2022","author":"Yang","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0255","first-page":"1008","article-title":"Proteasome inhibitor-induced IkappaB\/NF-kappaB activation is mediated by Nrf2-dependent light chain 3B induction in lung cancer cells","volume":"41","author":"Lee","year":"2018","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bcp.2026.117989_b0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","article-title":"Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway","volume":"23","author":"Yu","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.117989_b0265","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK","volume":"1783","author":"Liu","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.117989_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103335","article-title":"Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling","volume":"24","author":"Wang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2026.117989_b0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2174\/1389450124666230330135834","article-title":"Targeting hepatic stellate cell death to reverse hepatic fibrosis","volume":"24","author":"Zhang","year":"2023","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2026.117989_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201044","article-title":"Nrf2 protects stellate cells from Smad-dependent cell activation","volume":"13","author":"Prestigiacomo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117989_b0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acsptsci.2c00165","article-title":"Cell-permeable PROTAC degraders against KEAP1 efficiently suppress hepatic stellate cell activation through the antioxidant and anti-inflammatory pathway","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0290","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0295","article-title":"Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice","volume":"5","author":"Seedorf","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.bcp.2026.117989_b0300","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002656RRR","article-title":"BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model","volume":"35","author":"Kim","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.117989_b0305","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.redox.2017.06.008","article-title":"Non-alcoholic fatty liver disease, to struggle with the strangle: oxygen availability in fatty livers","volume":"13","author":"Anavi","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bcp.2026.117989_b0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12967-015-0383-6","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles","volume":"13","author":"Yuan","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13105-021-00850-9","article-title":"Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2","volume":"78","author":"Shatoor","year":"2022","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2026.117989_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177003","article-title":"Asperuloside activates hepatic NRF2 signaling to stimulate mitochondrial metabolism and restore lipid homeostasis in high fat diet-induced MAFLD","volume":"983","author":"He","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0335","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcp.2017.04.014","article-title":"Apigenin, a modulator of PPARgamma, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation","volume":"136","author":"Feng","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","article-title":"Autophagy in the liver: Functions in health and disease","volume":"14","author":"Ueno","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2026.117989_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154746","article-title":"Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy","volume":"113","author":"Yu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0355","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/cells11162511","article-title":"Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review","volume":"11","author":"Nasiri-Ansari","year":"2022","journal-title":"Cells-Basel"},{"key":"10.1016\/j.bcp.2026.117989_b0360","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0365","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202170023","article-title":"Sulforaphane improves lipid metabolism by enhancing mitochondrial function and biogenesis in vivo and in vitro","volume":"65","author":"Lei","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bcp.2026.117989_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175744","article-title":"Erianin alleviated liver steatosis by enhancing Nrf2-mediated VE-cadherin expression in vascular endothelium","volume":"950","author":"Wei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172618","article-title":"Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK\/SIRT1 signaling pathway in HepG2 cells","volume":"861","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0380","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.3390\/ijms24119540","article-title":"GB1a activates SIRT6 to regulate lipid metabolism in mouse primary hepatocytes","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0385","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/antiox14121449","article-title":"Cuspidatyl ferulate, a novel phenolic acid from hyssopus cuspidatus borris, protects hepatocytes against oxidative damage via keap1 interaction","volume":"14","author":"Liu","year":"2025","journal-title":"Antioxidants (basel)."},{"key":"10.1016\/j.bcp.2026.117989_b0390","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.646239","article-title":"P-Hydroxybenzyl alcohol alleviates oxidative stress in a nonalcoholic fatty liver disease larval zebrafish model and a BRL-3A hepatocyte via the nrf2 pathway","volume":"12","author":"An","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0395","first-page":"445","article-title":"Kaempferol-3-O-glucuronide ameliorates non-alcoholic steatohepatitis in high-cholesterol-diet-induced larval zebrafish and HepG2 cell models via regulating oxidation stress","volume":"11","author":"Deng","year":"2021","journal-title":"Life (basel)"},{"key":"10.1016\/j.bcp.2026.117989_b0400","doi-asserted-by":"crossref","first-page":"10620","DOI":"10.1021\/acs.jafc.2c04476","article-title":"Astaxanthin alleviates nonalcoholic fatty liver disease by regulating the intestinal flora and targeting the AMPK\/Nrf2 signal axis","volume":"70","author":"Li","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2026.117989_b0405","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.12659\/MSM.907530","article-title":"Scutellarin prevents nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia via PI3K\/AKT-dependent activation of nuclear factor (Erythroid-Derived 2)-like 2 (Nrf2) in rats","volume":"23","author":"Fan","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bcp.2026.117989_b0410","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.pharep.2019.07.002","article-title":"Hepatoprotective potential of 7,8-dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-kappaB activation","volume":"71","author":"Kumar","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2026.117989_b0415","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.3390\/nu13124484","article-title":"Protective effects of sesamol against liver oxidative stress and inflammation in high-fat diet-induced hepatic steatosis","volume":"13","author":"Zheng","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117989_b0420","article-title":"Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH)","volume":"285","author":"Abd","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0425","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/D1FO02989D","article-title":"Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice","volume":"13","author":"Ke","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2026.117989_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1049818","article-title":"Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2\/HO-1 pathway","volume":"13","author":"Pengnet","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121688","article-title":"Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats","volume":"322","author":"Farage","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0440","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3390\/molecules28062570","article-title":"Nobiletin intake attenuates hepatic lipid profiling and oxidative stress in HFD-induced nonalcoholic-fatty-liver-disease mice","volume":"28","author":"Ke","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117989_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102231","article-title":"Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1\/Akt\/PPRA-alpha\/AMPK and Nrf-2\/HO-1 signaling pathways","volume":"47","author":"Tamilmani","year":"2023","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.117989_b0450","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22150","article-title":"Costunolide attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease","volume":"85","author":"Wang","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0455","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejphar.2014.06.006","article-title":"Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats","volume":"738","author":"Xin","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0460","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1007\/s10620-018-5268-0","article-title":"Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the NF-kappaB pathway","volume":"63","author":"Ou","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0465","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117989_b0470","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/bcpt.13122","article-title":"Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice","volume":"124","author":"Liu","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2026.117989_b0475","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10799893.2021.1905665","article-title":"SIRT1\/NFkappaB pathway mediates anti-inflammatory and anti-apoptotic effects of rosmarinic acid on in a mouse model of nonalcoholic steatohepatitis (NASH)","volume":"42","author":"Komeili-Movahhed","year":"2022","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157614","article-title":"Novel dual AMPK\/NRF2 activation by leucocyanidin from Hawthorn (Crataegus) for mitochondria repair-Targeted therapy of hepatic steatosis","volume":"150","author":"Li","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0485","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/nu10050531","article-title":"Ellagic acid alleviates hepatic oxidative stress and insulin resistance in diabetic female rats","volume":"10","author":"Polce","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117989_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2020.12.020","article-title":"Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress","volume":"164","author":"Zhang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0495","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jpp\/rgab032","article-title":"Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats","volume":"73","author":"Fawzy","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0500","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK\/Nrf2 pathway","volume":"30","author":"Qu","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173244","article-title":"Berbamine induced AMPK activation regulates mTOR\/SREBP-1c axis and Nrf2\/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells","volume":"882","author":"Sharma","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0510","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/antiox10071076","article-title":"Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): insights into the role of oxidative stress and antioxidant mechanism","volume":"10","author":"Tang","year":"2021","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.117989_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110461","article-title":"Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS\/TLR4\/MyD88 signaling pathway","volume":"376","author":"Gu","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.117989_b0520","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/08923973.2021.1984520","article-title":"Capillin protects against non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation and oxidative stress","volume":"43","author":"Li","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bcp.2026.117989_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111504","article-title":"4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation","volume":"138","author":"Yen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117989_b0530","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2020.05.050","article-title":"Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice","volume":"528","author":"Takatani","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.117989_b0535","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/md20040225","article-title":"Fucoxanthin attenuates free fatty acid-Induced nonalcoholic fatty liver disease by regulating lipid metabolism\/oxidative stress\/inflammation via the AMPK\/Nrf2\/TLR4 signaling pathway","volume":"20","author":"Ye","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2026.117989_b0540","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202001031","article-title":"Punicalagin prevents hepatic steatosis through improving lipid homeostasis and inflammation in liver and adipose tissue and modulating gut microbiota in western Diet-Fed mice","volume":"65","author":"Liu","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bcp.2026.117989_b0545","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/mnfr.201500490","article-title":"Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system","volume":"60","author":"Yan","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bcp.2026.117989_b0550","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1039\/C7FO01051F","article-title":"Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation","volume":"9","author":"Xia","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2026.117989_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0560","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6610124","article-title":"Bixin attenuates high-fat diet-caused liver steatosis and inflammatory injury through Nrf2\/PPARalpha signals","volume":"2021","author":"Tao","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2026.117989_b0565","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3945\/jn.111.157263","article-title":"Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats","volume":"142","author":"Panchal","year":"2012","journal-title":"J. Nutr."},{"key":"10.1016\/j.bcp.2026.117989_b0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12986-015-0030-5","article-title":"Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1","volume":"12","author":"Kim","year":"2015","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.bcp.2026.117989_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156317","article-title":"Asiaticoside alleviated NAFLD by activating Nrf2 and inhibiting the NF-\u03baB pathway","volume":"136","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0580","doi-asserted-by":"crossref","first-page":"34888","DOI":"10.1038\/s41598-025-18477-x","article-title":"Aloesin activates Nrf2 signaling to attenuate obesity-associated oxidative stress and hepatic steatosis in high-fat diet-fed rats","volume":"15","author":"Alamri","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117989_b0585","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10565-024-09953-7","article-title":"Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway","volume":"40","author":"Feng","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2026.117989_b0590","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2024.08.038","article-title":"Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1","volume":"224","author":"Zhang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155756","article-title":"Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0600","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117989_b0605","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117989_b0610","first-page":"436","article-title":"Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis, Cell","volume":"27","author":"Anandhan","year":"2020","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0615","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1286449","article-title":"Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0620","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.3390\/ijms241512510","article-title":"Icariin supplementation suppresses the markers of ferroptosis and attenuates the progression of nonalcoholic steatohepatitis in mice fed a methionine choline-deficient diet","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0625","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","article-title":"Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation","volume":"22","author":"Yang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bcp.2026.117989_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18321","article-title":"Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis","volume":"9","author":"Ye","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.117989_b0635","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11418-021-01491-4","article-title":"Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1\/Nrf2-ARE signaling pathway to reduce ferroptosis","volume":"75","author":"Gao","year":"2021","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152599","article-title":"Study on the attenuated effect of ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease","volume":"445","author":"Yang","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2026.117989_b0645","article-title":"Oroxylin a ameliorates non-alcoholic fatty liver disease by modulating oxidative stress and ferroptosis through the Nrf2 pathway","volume":"1870","author":"Jiang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2026.117989_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157762","article-title":"Gastrodin ameliorates nonalcoholic fatty liver disease via inhibiting hepatic ferroptosis by the Keap1\/Nrf2 signaling pathway","volume":"151","author":"Zhang","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156472","article-title":"Hinokitiol ameliorates MASH in mice by therapeutic targeting of hepatic Nrf2 and inhibiting hepatocyte ferroptosis","volume":"139","author":"Yin","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0660","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.117989_b0665","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0670","doi-asserted-by":"crossref","unstructured":"K.M. Holmstr M, L. Baird, Y. Zhang, I. Hargreaves, A. Chalasani, J.M. Land et al., Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration, Biol. Open 2 (2013) 761-770.","DOI":"10.1242\/bio.20134853"},{"key":"10.1016\/j.bcp.2026.117989_b0675","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","article-title":"Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice","volume":"298","author":"Sugimoto","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2026.117989_b0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291880","article-title":"Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from Porphyromonas gingivalis through enhanced hepatic clearance","volume":"18","author":"Chihara","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117989_b0685","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/D0FO02684K","article-title":"Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2\/HO-1 signaling","volume":"12","author":"Xu","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2026.117989_b0690","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/ptr.8010","article-title":"Baicalin attenuated metabolic dysfunction-associated fatty liver disease by suppressing oxidative stress and inflammation via the p62-Keap1-Nrf2 signalling pathway in db\/db mice","volume":"39","author":"Liu","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175270","article-title":"Baicalin improved hepatic injury of NASH by regulating NRF2\/HO-1\/NRLP3 pathway","volume":"934","author":"Shi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0700","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2026.117989_b0705","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4155\/fmc-2021-0241","article-title":"Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2\/RAGE\/NF-kappaB signaling pathway","volume":"13","author":"Wang","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2026.117989_b0710","article-title":"Artesunate reduces oxidative stress and inflammation in NAFLD by activating the Nrf2 pathway","volume":"245","author":"Meng","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0715","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1111\/jcmm.15139","article-title":"Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signalling pathways","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0720","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109895","article-title":"Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS\/P38\/Nrf2 axis and PI3K\/AKT\/mTOR pathway in macrophages","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117989_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2026.117989_b0735","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117989_b0740","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.04943.x","article-title":"Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis","volume":"22","author":"Hyogo","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117989_b0745","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tiv.2016.03.013","article-title":"Chebulic acid prevents hepatic fibrosis induced by advanced glycation end-products in LX-2 cell by modulating Nrf2 translocation via ERK pathway","volume":"34","author":"Koo","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2026.117989_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116626","article-title":"Geniposide ameliorates dextran sulfate sodium-induced ulcerative colitis via KEAP1-Nrf2 signaling pathway","volume":"314","author":"Zhuge","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154962","article-title":"Berberine ameliorates iron levels and ferroptosis in the brain of 3 x Tg-AD mice","volume":"118","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0760","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.8498","article-title":"Nrf2-mediated ferroptosis is involved in berberine-induced alleviation of diabetic kidney disease","author":"Gao","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0765","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/ars.2024.0593","article-title":"Asperuloside as a novel NRF2 activator to ameliorate endothelial dysfunction in high fat diet-induced obese mice","volume":"42","author":"He","year":"2025","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.117989_b0770","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2024.12.036","article-title":"Baicalein disrupts the KEAP1-NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization","volume":"227","author":"Chi","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155696","article-title":"Targeting the smooth muscle cell KEAP1-Nrf2-STING axis with pterostilbene attenuates abdominal aortic aneurysm","volume":"130","author":"Zou","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154887","article-title":"Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis","volume":"126","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102511","article-title":"A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis","volume":"57","author":"Luo","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118353","article-title":"Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection","volume":"332","author":"Chi","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117989_b0795","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117989_b0800","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.117989_b0805","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/antiox9121228","article-title":"Anti-viral potential and modulation of Nrf2 by curcumin: pharmacological implications","volume":"9","author":"Rahban","year":"2020","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.117989_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155458","article-title":"Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2\/xCT\/GPX4 signaling pathway","volume":"126","author":"Deng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0815","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2012.12.002","article-title":"Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage","volume":"17","author":"Bae","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.117989_b0820","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.18632\/aging.103132","article-title":"Lycopene prevents carcinogen-induced cutaneous tumor by enhancing activation of the Nrf2 pathway through p62-triggered autophagic Keap1 degradation","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2026.117989_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156684","article-title":"Erianin alleviates doxorubicin-induced cardiotoxicity by activating the Keap1-Nrf2 signaling pathway","volume":"141","author":"Kang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117989_b0830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2021.03.034","article-title":"Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications","volume":"168","author":"Liu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0835","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.freeradbiomed.2016.09.009","article-title":"Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis","volume":"99","author":"Lee","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117989_b0840","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1468476","article-title":"Potential impact of ezetimibe on patients with NAFLD\/NASH: a meta-analysis of randomized controlled trials","volume":"15","author":"Jiao","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117989_b0845","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.numecd.2022.01.024","article-title":"Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): a double-blind randomised placebo-controlled trial","volume":"32","author":"Noto","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.bcp.2026.117989_b0850","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0855","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/ptr.7806","article-title":"Berberine and health outcomes: an umbrella review","volume":"37","author":"Li","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.117989_b0860","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/molecules22101689","article-title":"A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product","volume":"22","author":"Shan","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117989_b0865","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15376516.2021.2023828","article-title":"The absence of genotoxicity of a mixture of aloin a and B and a commercial aloe gel beverage","volume":"32","author":"Hayes","year":"2022","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.bcp.2026.117989_b0870","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/ijms21062084","article-title":"Potential adverse effects of resveratrol: a literature review","volume":"21","author":"Shaito","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117989_b0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105109","article-title":"New progress in the pharmacology of protocatechuic acid: a compound ingested in daily foods and herbs frequently and heavily","volume":"161","author":"Song","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:18:13Z","timestamp":1780676293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":175,"alternative-id":["S0006295226003229"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117989","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic role of natural compounds mediated through Nrf2 in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117989"}}